Strategies to Maintain the Remission of Diabetes Following Metabolic Surgery.
Mi Kyung KimHye Soon KimPublished in: Journal of metabolic and bariatric surgery (2023)
Obesity is a major risk factor for type 2 diabetes mellitus (T2DM). Bariatric surgery is the most effective means of inducing weight loss, and can ameliorate or induce the remission of obesity-related metabolic comorbidities, including T2DM. The guidelines for the management of T2DM emphasize weight management and recommend metabolic surgery for the treatment of T2DM accompanied by obesity. However, despite the clear beneficial effects of metabolic surgery, only 20-50% of patients who experience remission will stay in remission over the long term. Moreover, the beneficial effects of metabolic surgery tend to diminish with time, and a subset of patients experience a relapse of their diabetes. Therefore, in the present review, we discuss potential strategies for the maintenance of diabetic remission following metabolic surgery.
Keyphrases
- weight loss
- minimally invasive
- bariatric surgery
- glycemic control
- coronary artery bypass
- type diabetes
- insulin resistance
- surgical site infection
- metabolic syndrome
- disease activity
- roux en y gastric bypass
- weight gain
- cardiovascular disease
- ulcerative colitis
- end stage renal disease
- gastric bypass
- body mass index
- chronic kidney disease
- obese patients
- physical activity
- coronary artery disease
- newly diagnosed
- climate change
- atrial fibrillation
- patient reported outcomes
- wound healing
- replacement therapy